

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.77281619 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.61974185 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.61974185 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.48606364 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.48606364 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21626140 |
| 7 | negative T cell selection (GO:0043383) | 5.14596428 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.08728336 |
| 9 | negative thymic T cell selection (GO:0045060) | 5.07967558 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.81243210 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.69661066 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.65464178 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.64046369 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.53340673 |
| 15 | interferon-gamma production (GO:0032609) | 4.25912596 |
| 16 | * T cell migration (GO:0072678) | 4.15451063 |
| 17 | thymic T cell selection (GO:0045061) | 4.06065439 |
| 18 | positive T cell selection (GO:0043368) | 3.99819155 |
| 19 | regulation of B cell differentiation (GO:0045577) | 3.97308753 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 3.96880015 |
| 21 | T cell selection (GO:0045058) | 3.96547866 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 3.90148381 |
| 23 | response to interleukin-15 (GO:0070672) | 3.90084384 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 3.90061581 |
| 25 | leukocyte aggregation (GO:0070486) | 3.81889893 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.78370299 |
| 27 | Peyers patch development (GO:0048541) | 3.68889019 |
| 28 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.68889019 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 3.65429744 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.53930547 |
| 31 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.53809316 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.53559136 |
| 33 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.50692544 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.47222290 |
| 35 | response to peptidoglycan (GO:0032494) | 3.46798163 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.45552575 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.45552575 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.45552575 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.45552575 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.45552575 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.45552575 |
| 42 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.42372013 |
| 43 | neutrophil activation (GO:0042119) | 3.42242844 |
| 44 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.38774758 |
| 45 | regulation of granulocyte differentiation (GO:0030852) | 3.38612657 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33043939 |
| 47 | tolerance induction (GO:0002507) | 3.31309975 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.29685498 |
| 49 | regulation of tolerance induction (GO:0002643) | 3.29392409 |
| 50 | positive regulation of isotype switching (GO:0045830) | 3.28913080 |
| 51 | microglial cell activation (GO:0001774) | 3.28468878 |
| 52 | activated T cell proliferation (GO:0050798) | 3.27974443 |
| 53 | T cell homeostasis (GO:0043029) | 3.26948514 |
| 54 | detection of other organism (GO:0098543) | 3.26640690 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.23612139 |
| 56 | response to type I interferon (GO:0034340) | 3.22323985 |
| 57 | mast cell activation involved in immune response (GO:0002279) | 3.21687246 |
| 58 | mast cell degranulation (GO:0043303) | 3.21687246 |
| 59 | mast cell activation (GO:0045576) | 3.21349992 |
| 60 | myeloid dendritic cell activation (GO:0001773) | 3.19107575 |
| 61 | positive regulation of interleukin-2 production (GO:0032743) | 3.17644624 |
| 62 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.16549216 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16448350 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.15976111 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.15976111 |
| 66 | granulocyte activation (GO:0036230) | 3.14720552 |
| 67 | T cell receptor signaling pathway (GO:0050852) | 3.14393117 |
| 68 | response to muramyl dipeptide (GO:0032495) | 3.12970027 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.12301176 |
| 70 | mature B cell differentiation (GO:0002335) | 3.11501882 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 3.11440091 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 3.09058479 |
| 73 | lymphocyte homeostasis (GO:0002260) | 3.07711942 |
| 74 | * leukocyte cell-cell adhesion (GO:0007159) | 3.07569228 |
| 75 | detection of bacterium (GO:0016045) | 3.07467590 |
| 76 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.06921498 |
| 77 | T cell costimulation (GO:0031295) | 3.06006472 |
| 78 | positive regulation of interferon-alpha production (GO:0032727) | 3.05810668 |
| 79 | B cell homeostasis (GO:0001782) | 3.05728392 |
| 80 | leukocyte degranulation (GO:0043299) | 3.04201299 |
| 81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03291789 |
| 82 | natural killer cell activation (GO:0030101) | 3.02962588 |
| 83 | T cell proliferation (GO:0042098) | 3.02736141 |
| 84 | lymphocyte costimulation (GO:0031294) | 3.01103295 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.99950222 |
| 86 | immunoglobulin mediated immune response (GO:0016064) | 2.99622054 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97587695 |
| 88 | response to host immune response (GO:0052572) | 2.97570131 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.97570131 |
| 90 | megakaryocyte development (GO:0035855) | 2.97359481 |
| 91 | natural killer cell differentiation (GO:0001779) | 2.96476297 |
| 92 | regulation of interferon-alpha production (GO:0032647) | 2.96445838 |
| 93 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95624205 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94535376 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.92293735 |
| 96 | negative regulation of phagocytosis (GO:0050765) | 2.90973284 |
| 97 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90932342 |
| 98 | cellular extravasation (GO:0045123) | 2.90428000 |
| 99 | detection of molecule of bacterial origin (GO:0032490) | 2.90098685 |
| 100 | detection of external biotic stimulus (GO:0098581) | 2.88085847 |
| 101 | positive regulation of granulocyte differentiation (GO:0030854) | 2.87792859 |
| 102 | negative regulation of interleukin-12 production (GO:0032695) | 2.86948749 |
| 103 | regulation of mast cell degranulation (GO:0043304) | 2.86103132 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.84992857 |
| 105 | germinal center formation (GO:0002467) | 2.83875547 |
| 106 | positive regulation of DNA recombination (GO:0045911) | 2.82788522 |
| 107 | negative regulation of B cell proliferation (GO:0030889) | 2.82214009 |
| 108 | positive regulation of mast cell activation (GO:0033005) | 2.80984493 |
| 109 | alpha-beta T cell activation (GO:0046631) | 2.80977690 |
| 110 | neutrophil mediated immunity (GO:0002446) | 2.79974402 |
| 111 | negative regulation of adaptive immune response (GO:0002820) | 2.79837270 |
| 112 | respiratory burst (GO:0045730) | 2.79744770 |
| 113 | positive regulation of tolerance induction (GO:0002645) | 2.79171080 |
| 114 | defense response to protozoan (GO:0042832) | 2.79054181 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.77724818 |
| 116 | myeloid dendritic cell differentiation (GO:0043011) | 2.77718510 |
| 117 | regulation of hypersensitivity (GO:0002883) | 2.77549669 |
| 118 | regulation of alpha-beta T cell activation (GO:0046634) | 2.77222969 |
| 119 | response to host defenses (GO:0052200) | 2.76511658 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.76511658 |
| 121 | response to host (GO:0075136) | 2.76511658 |
| 122 | positive regulation of B cell activation (GO:0050871) | 2.75359852 |
| 123 | positive regulation of humoral immune response (GO:0002922) | 2.74321073 |
| 124 | response to protozoan (GO:0001562) | 2.74232812 |
| 125 | hepatocyte apoptotic process (GO:0097284) | 2.72535409 |
| 126 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.71629163 |
| 127 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.71629163 |
| 128 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.71319072 |
| 129 | positive regulation of B cell mediated immunity (GO:0002714) | 2.71319072 |
| 130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70823402 |
| 131 | leukocyte homeostasis (GO:0001776) | 2.68643228 |
| 132 | regulation of necroptotic process (GO:0060544) | 2.67443772 |
| 133 | regulation of response to interferon-gamma (GO:0060330) | 2.65805280 |
| 134 | B cell proliferation (GO:0042100) | 2.64928258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.92894997 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.33376024 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.13233942 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.96015779 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.07458349 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91570126 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.67787198 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.40051979 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31808409 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.25889927 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.00230662 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.99284170 |
| 13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.98958041 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.96659642 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93528538 |
| 16 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.93244198 |
| 17 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.89171233 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.80591968 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.79377437 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67861349 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66389410 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.53293150 |
| 23 | * MYB_26560356_Chip-Seq_TH1_Human | 2.46777905 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45585819 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.44722191 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25598721 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25189100 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.23345696 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18253262 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.15387358 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14786830 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10462533 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01085071 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99626502 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96479606 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94074892 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84096704 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83770611 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74919797 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73414239 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71759389 |
| 42 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69273231 |
| 43 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67166625 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64469551 |
| 45 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57170957 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55551332 |
| 47 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.54705501 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54696550 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.52268145 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.48296986 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46999748 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45822341 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45236350 |
| 54 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42864542 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42730584 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41961924 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.41026864 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40319194 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36688229 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33497038 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31567701 |
| 62 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30905087 |
| 63 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.29861052 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26529944 |
| 65 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26478412 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25946133 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25680748 |
| 68 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22164303 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19338453 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18521972 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18266574 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17172018 |
| 73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15046002 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13887969 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12992770 |
| 76 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12454151 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10797243 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07028832 |
| 79 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04376030 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04327212 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03489862 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00979330 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98021542 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96139471 |
| 85 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94373749 |
| 86 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.93868584 |
| 87 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93806265 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93372592 |
| 89 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90476344 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88754012 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86773568 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85145500 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84977163 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83440965 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82767171 |
| 96 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81432002 |
| 97 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.80685180 |
| 98 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80066680 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79832332 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79322917 |
| 101 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79306125 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77975527 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77758173 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77710403 |
| 105 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77666389 |
| 106 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.75763769 |
| 107 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.75206013 |
| 108 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.72445395 |
| 109 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70167872 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.68528920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.02844813 |
| 2 | MP0005671_abnormal_response_to | 3.52137407 |
| 3 | MP0000685_abnormal_immune_system | 3.38604021 |
| 4 | MP0001800_abnormal_humoral_immune | 3.29460736 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.24853473 |
| 6 | MP0005387_immune_system_phenotype | 3.12286200 |
| 7 | MP0001790_abnormal_immune_system | 3.12286200 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.88840869 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.87485133 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.82016538 |
| 11 | MP0002723_abnormal_immune_serum | 2.78374676 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.74582177 |
| 13 | * MP0001819_abnormal_immune_cell | 2.72867608 |
| 14 | MP0009785_altered_susceptibility_to | 2.70947910 |
| 15 | * MP0002398_abnormal_bone_marrow | 2.67055778 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.65434977 |
| 17 | MP0005025_abnormal_response_to | 2.59393813 |
| 18 | MP0003436_decreased_susceptibility_to | 2.59160465 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.45065686 |
| 20 | * MP0002419_abnormal_innate_immunity | 2.40532644 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.36120678 |
| 22 | * MP0000716_abnormal_immune_system | 2.35347879 |
| 23 | MP0001873_stomach_inflammation | 2.32975710 |
| 24 | MP0003303_peritoneal_inflammation | 2.28416328 |
| 25 | MP0002006_tumorigenesis | 2.25751643 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.17137794 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 2.15294502 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.13055142 |
| 29 | MP0002405_respiratory_system_inflammati | 2.09169227 |
| 30 | * MP0002722_abnormal_immune_system | 2.07362845 |
| 31 | MP0000703_abnormal_thymus_morphology | 1.99218464 |
| 32 | MP0006082_CNS_inflammation | 1.98135700 |
| 33 | * MP0002429_abnormal_blood_cell | 1.97207992 |
| 34 | MP0004381_abnormal_hair_follicle | 1.94565523 |
| 35 | MP0005174_abnormal_tail_pigmentation | 1.93490405 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.93437322 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.93279149 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.93279149 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.90105694 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.87852661 |
| 41 | MP0009278_abnormal_bone_marrow | 1.84486675 |
| 42 | MP0004947_skin_inflammation | 1.81925017 |
| 43 | MP0003724_increased_susceptibility_to | 1.79679135 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.68803122 |
| 45 | MP0004510_myositis | 1.64283728 |
| 46 | MP0001853_heart_inflammation | 1.60727339 |
| 47 | MP0008057_abnormal_DNA_replication | 1.49587395 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.46408882 |
| 49 | MP0008260_abnormal_autophagy | 1.44023187 |
| 50 | MP0000490_abnormal_crypts_of | 1.41160266 |
| 51 | MP0000858_altered_metastatic_potential | 1.38685412 |
| 52 | MP0003866_abnormal_defecation | 1.38241347 |
| 53 | MP0005310_abnormal_salivary_gland | 1.38130544 |
| 54 | MP0003448_altered_tumor_morphology | 1.32066471 |
| 55 | MP0002009_preneoplasia | 1.29346427 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.27368019 |
| 57 | MP0002933_joint_inflammation | 1.22101578 |
| 58 | MP0008469_abnormal_protein_level | 1.20776429 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.20577771 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.19543075 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.16729717 |
| 62 | MP0010307_abnormal_tumor_latency | 1.11713257 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.11147498 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.08177716 |
| 65 | MP0004883_abnormal_blood_vessel | 1.07695162 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.04463560 |
| 67 | MP0010094_abnormal_chromosome_stability | 1.03570132 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.03525377 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.99761113 |
| 70 | MP0005451_abnormal_body_composition | 0.99305210 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 0.97988382 |
| 72 | MP0002095_abnormal_skin_pigmentation | 0.97477615 |
| 73 | MP0009764_decreased_sensitivity_to | 0.94978048 |
| 74 | MP0003077_abnormal_cell_cycle | 0.93803212 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.90479358 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.88898760 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.87419785 |
| 78 | MP0005164_abnormal_response_to | 0.81728475 |
| 79 | MP0003111_abnormal_nucleus_morphology | 0.81266436 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.75977520 |
| 81 | MP0000371_diluted_coat_color | 0.75158777 |
| 82 | MP0001851_eye_inflammation | 0.74181833 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73608182 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.73498132 |
| 85 | MP0006054_spinal_hemorrhage | 0.73234118 |
| 86 | MP0009763_increased_sensitivity_to | 0.72359387 |
| 87 | MP0008007_abnormal_cellular_replicative | 0.71657984 |
| 88 | MP0002132_abnormal_respiratory_system | 0.71561639 |
| 89 | MP0008877_abnormal_DNA_methylation | 0.70533812 |
| 90 | MP0003693_abnormal_embryo_hatching | 0.70162201 |
| 91 | MP0008058_abnormal_DNA_repair | 0.69998249 |
| 92 | MP0003787_abnormal_imprinting | 0.69290653 |
| 93 | MP0003828_pulmonary_edema | 0.69112450 |
| 94 | MP0003045_fibrosis | 0.68983933 |
| 95 | MP0000604_amyloidosis | 0.65484626 |
| 96 | MP0003091_abnormal_cell_migration | 0.65272190 |
| 97 | MP0003943_abnormal_hepatobiliary_system | 0.64271702 |
| 98 | MP0002928_abnormal_bile_duct | 0.63238747 |
| 99 | MP0000313_abnormal_cell_death | 0.62736752 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.62697303 |
| 101 | MP0001663_abnormal_digestive_system | 0.62581787 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 0.62265992 |
| 103 | MP0001986_abnormal_taste_sensitivity | 0.56476561 |
| 104 | MP0005390_skeleton_phenotype | 0.55878534 |
| 105 | MP0000343_altered_response_to | 0.55244574 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.53496460 |
| 107 | MP0004130_abnormal_muscle_cell | 0.53479246 |
| 108 | MP0000249_abnormal_blood_vessel | 0.51506910 |
| 109 | MP0003279_aneurysm | 0.50951004 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.50803953 |
| 111 | MP0003690_abnormal_glial_cell | 0.50803559 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.50117683 |
| 113 | MP0003795_abnormal_bone_structure | 0.48983890 |
| 114 | MP0005166_decreased_susceptibility_to | 0.48922572 |
| 115 | * MP0005621_abnormal_cell_physiology | 0.47817105 |
| 116 | MP0001191_abnormal_skin_condition | 0.45999929 |
| 117 | MP0008873_increased_physiological_sensi | 0.45968365 |
| 118 | MP0003075_altered_response_to | 0.44855979 |
| 119 | MP0002163_abnormal_gland_morphology | 0.43762401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent viral infections (HP:0004429) | 4.84805066 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.76310418 |
| 3 | T lymphocytopenia (HP:0005403) | 4.59894513 |
| 4 | Abnormality of T cell number (HP:0011839) | 4.46160061 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.41782707 |
| 6 | Myositis (HP:0100614) | 4.34038304 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.28021305 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.99897441 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.94247829 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.91189145 |
| 11 | Chronic otitis media (HP:0000389) | 3.90767494 |
| 12 | IgM deficiency (HP:0002850) | 3.86949841 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.81608529 |
| 14 | Optic neuritis (HP:0100653) | 3.81608529 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.81365581 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.77828906 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71274816 |
| 18 | Meningitis (HP:0001287) | 3.70776216 |
| 19 | Abnormality of T cells (HP:0002843) | 3.59806920 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.55718268 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52134637 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52134637 |
| 23 | Orchitis (HP:0100796) | 3.49643438 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.44409485 |
| 25 | Vasculitis (HP:0002633) | 3.38446192 |
| 26 | Autoimmune thrombocytopenia (HP:0001973) | 3.34703493 |
| 27 | Pustule (HP:0200039) | 3.32057843 |
| 28 | Nasal polyposis (HP:0100582) | 3.31732163 |
| 29 | Inflammation of the large intestine (HP:0002037) | 3.28118204 |
| 30 | Thyroiditis (HP:0100646) | 3.26214486 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.26180445 |
| 32 | Cellulitis (HP:0100658) | 3.25758819 |
| 33 | Recurrent skin infections (HP:0001581) | 3.24584887 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 3.14570237 |
| 35 | Colitis (HP:0002583) | 3.10415182 |
| 36 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.04897460 |
| 37 | Eosinophilia (HP:0001880) | 3.01879266 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.99660033 |
| 39 | Obstructive lung disease (HP:0006536) | 2.99465507 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99465507 |
| 41 | Encephalitis (HP:0002383) | 2.95927763 |
| 42 | Leukocytosis (HP:0001974) | 2.88012977 |
| 43 | B lymphocytopenia (HP:0010976) | 2.87639816 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.87639816 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.85254980 |
| 46 | Arterial thrombosis (HP:0004420) | 2.81731999 |
| 47 | Periodontitis (HP:0000704) | 2.81698870 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.81069031 |
| 49 | Lymphopenia (HP:0001888) | 2.80069044 |
| 50 | IgG deficiency (HP:0004315) | 2.75991572 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.75114437 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74828875 |
| 53 | Abnormality of eosinophils (HP:0001879) | 2.73417746 |
| 54 | Severe combined immunodeficiency (HP:0004430) | 2.73326919 |
| 55 | Thrombocytosis (HP:0001894) | 2.73307745 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.71104968 |
| 57 | Granulocytopenia (HP:0001913) | 2.68687243 |
| 58 | Verrucae (HP:0200043) | 2.66439902 |
| 59 | Papilloma (HP:0012740) | 2.66439902 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.66246322 |
| 61 | Epistaxis (HP:0000421) | 2.65205006 |
| 62 | Viral hepatitis (HP:0006562) | 2.64571000 |
| 63 | Combined immunodeficiency (HP:0005387) | 2.63076678 |
| 64 | Increased IgM level (HP:0003496) | 2.60931330 |
| 65 | Petechiae (HP:0000967) | 2.59663426 |
| 66 | Hemoptysis (HP:0002105) | 2.57061586 |
| 67 | Abnormality of macrophages (HP:0004311) | 2.55047130 |
| 68 | Increased IgE level (HP:0003212) | 2.51606403 |
| 69 | Urticaria (HP:0001025) | 2.51492935 |
| 70 | Abnormality of the prostate (HP:0008775) | 2.49879467 |
| 71 | Stomatitis (HP:0010280) | 2.47024663 |
| 72 | Gingival bleeding (HP:0000225) | 2.45178542 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.39666242 |
| 74 | Chronic diarrhea (HP:0002028) | 2.39559891 |
| 75 | Chest pain (HP:0100749) | 2.36198220 |
| 76 | Osteomyelitis (HP:0002754) | 2.36153913 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.32907757 |
| 78 | Gingivitis (HP:0000230) | 2.31568736 |
| 79 | Papilledema (HP:0001085) | 2.29687543 |
| 80 | Lymphoma (HP:0002665) | 2.29555756 |
| 81 | IgA deficiency (HP:0002720) | 2.29031877 |
| 82 | Acute myeloid leukemia (HP:0004808) | 2.28804160 |
| 83 | Acute hepatic failure (HP:0006554) | 2.27494240 |
| 84 | Recurrent sinusitis (HP:0011108) | 2.27441835 |
| 85 | Hematochezia (HP:0002573) | 2.26731920 |
| 86 | Chronic sinusitis (HP:0011109) | 2.25349068 |
| 87 | Acute lymphatic leukemia (HP:0006721) | 2.24819012 |
| 88 | Gastrointestinal stroma tumor (HP:0100723) | 2.23729800 |
| 89 | Spondylolisthesis (HP:0003302) | 2.22140560 |
| 90 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.16711256 |
| 91 | Slow saccadic eye movements (HP:0000514) | 2.15502666 |
| 92 | Impaired platelet aggregation (HP:0003540) | 2.14310777 |
| 93 | Abnormal platelet function (HP:0011869) | 2.14310777 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 2.08846995 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.08186902 |
| 96 | Peritonitis (HP:0002586) | 2.07379757 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.05532211 |
| 98 | Prostate neoplasm (HP:0100787) | 2.04790054 |
| 99 | Absent frontal sinuses (HP:0002688) | 2.00598341 |
| 100 | Recurrent pneumonia (HP:0006532) | 1.98720273 |
| 101 | Joint swelling (HP:0001386) | 1.98059122 |
| 102 | Microcytic anemia (HP:0001935) | 1.97918008 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 1.97015783 |
| 104 | Abnormality of the pleura (HP:0002103) | 1.96115628 |
| 105 | Fatigue (HP:0012378) | 1.95640489 |
| 106 | Skin ulcer (HP:0200042) | 1.94882883 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.94376928 |
| 108 | Pulmonary embolism (HP:0002204) | 1.93194758 |
| 109 | Anorexia (HP:0002039) | 1.92454554 |
| 110 | Hypochromic anemia (HP:0001931) | 1.91691813 |
| 111 | Gangrene (HP:0100758) | 1.90531368 |
| 112 | Sepsis (HP:0100806) | 1.90121739 |
| 113 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89566552 |
| 114 | Skin rash (HP:0000988) | 1.89468699 |
| 115 | Interstitial pulmonary disease (HP:0006530) | 1.88697257 |
| 116 | Bronchitis (HP:0012387) | 1.86316939 |
| 117 | Glomerulopathy (HP:0100820) | 1.86271415 |
| 118 | Emphysema (HP:0002097) | 1.84850270 |
| 119 | Amaurosis fugax (HP:0100576) | 1.83732938 |
| 120 | Spinal cord lesions (HP:0100561) | 1.83219676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.72528290 |
| 2 | TXK | 3.55849602 |
| 3 | JAK3 | 3.15888958 |
| 4 | TYK2 | 3.09293960 |
| 5 | MAP3K14 | 3.05336415 |
| 6 | PRPF4B | 3.04316847 |
| 7 | MAP3K13 | 2.28694551 |
| 8 | JAK1 | 2.25068596 |
| 9 | ITK | 2.24792642 |
| 10 | STK10 | 2.22261905 |
| 11 | IKBKE | 2.19647084 |
| 12 | IRAK4 | 2.14719320 |
| 13 | MAP3K10 | 2.04857182 |
| 14 | KIT | 2.04102888 |
| 15 | ZAP70 | 1.96948589 |
| 16 | BTK | 1.91682785 |
| 17 | GRK6 | 1.90782892 |
| 18 | TAOK3 | 1.85104267 |
| 19 | TBK1 | 1.84809771 |
| 20 | BLK | 1.83236943 |
| 21 | SYK | 1.81314817 |
| 22 | BMPR2 | 1.72502197 |
| 23 | TEC | 1.70146563 |
| 24 | IKBKB | 1.69715776 |
| 25 | FGFR3 | 1.68664819 |
| 26 | PIK3CG | 1.66636188 |
| 27 | CDK12 | 1.66443913 |
| 28 | RIPK4 | 1.65599173 |
| 29 | EEF2K | 1.62603779 |
| 30 | CSK | 1.58944165 |
| 31 | LCK | 1.57202151 |
| 32 | SIK2 | 1.50193900 |
| 33 | PIM1 | 1.47415740 |
| 34 | FGFR4 | 1.46867795 |
| 35 | HCK | 1.42540306 |
| 36 | IRAK3 | 1.39842735 |
| 37 | CSF1R | 1.38254684 |
| 38 | FES | 1.34312658 |
| 39 | CLK1 | 1.19122456 |
| 40 | CHUK | 1.16355658 |
| 41 | NLK | 1.15132839 |
| 42 | STK4 | 1.14145873 |
| 43 | MARK3 | 1.13053858 |
| 44 | RPS6KA4 | 1.07561433 |
| 45 | LYN | 1.05825859 |
| 46 | CDK4 | 1.00627051 |
| 47 | JAK2 | 0.99843663 |
| 48 | TGFBR2 | 0.99211116 |
| 49 | SCYL2 | 0.95137238 |
| 50 | PRKCQ | 0.93960831 |
| 51 | LRRK2 | 0.92953288 |
| 52 | BRD4 | 0.90594956 |
| 53 | SIK3 | 0.89178305 |
| 54 | TESK2 | 0.88990795 |
| 55 | CAMKK2 | 0.87493127 |
| 56 | EPHB1 | 0.86778804 |
| 57 | NEK2 | 0.85741630 |
| 58 | CDK9 | 0.83404344 |
| 59 | FLT3 | 0.82246142 |
| 60 | FGR | 0.81385894 |
| 61 | TRPM7 | 0.80605396 |
| 62 | TNK2 | 0.77174119 |
| 63 | CDK19 | 0.74629453 |
| 64 | MAP3K1 | 0.72967682 |
| 65 | CDK6 | 0.72184916 |
| 66 | MAP2K3 | 0.71622953 |
| 67 | WNK1 | 0.71033758 |
| 68 | HIPK2 | 0.70734945 |
| 69 | STK24 | 0.70603872 |
| 70 | MARK2 | 0.62652486 |
| 71 | CAMK1D | 0.62409441 |
| 72 | MELK | 0.61796608 |
| 73 | CDC7 | 0.61464592 |
| 74 | ATR | 0.61318074 |
| 75 | PASK | 0.60792975 |
| 76 | TTN | 0.60635549 |
| 77 | MAP3K7 | 0.59541094 |
| 78 | MAP3K3 | 0.59438455 |
| 79 | EPHA3 | 0.57328434 |
| 80 | PRKCH | 0.57223939 |
| 81 | TAOK2 | 0.57194456 |
| 82 | CAMKK1 | 0.55849076 |
| 83 | NUAK1 | 0.55569769 |
| 84 | CAMK1G | 0.53495350 |
| 85 | MST4 | 0.51144182 |
| 86 | PKN2 | 0.49672992 |
| 87 | NEK9 | 0.48807757 |
| 88 | SGK2 | 0.47817245 |
| 89 | ERN1 | 0.47648745 |
| 90 | MAP3K11 | 0.47405923 |
| 91 | SGK3 | 0.46047597 |
| 92 | MAPK11 | 0.44416263 |
| 93 | PDGFRB | 0.44009918 |
| 94 | STK3 | 0.42387438 |
| 95 | MAP3K5 | 0.41847025 |
| 96 | NME2 | 0.41300887 |
| 97 | PTK6 | 0.40971212 |
| 98 | GRK7 | 0.40036720 |
| 99 | MATK | 0.40021288 |
| 100 | RAF1 | 0.39885326 |
| 101 | RPS6KA5 | 0.39696324 |
| 102 | FRK | 0.39653559 |
| 103 | PDK1 | 0.38770357 |
| 104 | MAP3K6 | 0.38473950 |
| 105 | TRIB3 | 0.38445330 |
| 106 | RPS6KC1 | 0.37261742 |
| 107 | RPS6KL1 | 0.37261742 |
| 108 | KDR | 0.37071094 |
| 109 | RPS6KA6 | 0.36832437 |
| 110 | TAOK1 | 0.36426853 |
| 111 | ALK | 0.36217084 |
| 112 | MAP2K6 | 0.35448571 |
| 113 | PDPK1 | 0.35143624 |
| 114 | MAP2K2 | 0.33942807 |
| 115 | GRK5 | 0.33657970 |
| 116 | ABL1 | 0.33505931 |
| 117 | RPS6KB2 | 0.33411874 |
| 118 | SMG1 | 0.33194638 |
| 119 | EGFR | 0.32662387 |
| 120 | PIK3CA | 0.32226033 |
| 121 | IRAK2 | 0.32140757 |
| 122 | RET | 0.32059379 |
| 123 | MAPK4 | 0.32022359 |
| 124 | EIF2AK2 | 0.31838470 |
| 125 | MAPKAPK2 | 0.31459303 |
| 126 | YES1 | 0.31214241 |
| 127 | PRKAA2 | 0.29916453 |
| 128 | MAPK3 | 0.28456577 |
| 129 | MAPK7 | 0.27934376 |
| 130 | FYN | 0.27793865 |
| 131 | MAP3K8 | 0.27510122 |
| 132 | MAPK12 | 0.26873036 |
| 133 | IRAK1 | 0.26730812 |
| 134 | DMPK | 0.26346413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.61063233 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66708635 |
| 3 | Measles_Homo sapiens_hsa05162 | 2.50340998 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.49522221 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.42942971 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41133001 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35177510 |
| 8 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.34686188 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.23426086 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.19910563 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19109671 |
| 12 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06651555 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96006119 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.93562822 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89613605 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.87730057 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87458030 |
| 18 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83804648 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.82037223 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62260023 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.60359149 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55287875 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52211052 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52057968 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48202364 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.46227439 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44939527 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43049038 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39893982 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.35484157 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.35380634 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35313570 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.34989619 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29031573 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28442943 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24206497 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.19703172 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19591424 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.19240455 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17570832 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.16816039 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15830792 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.13660525 |
| 44 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07210020 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06122654 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.05646836 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.00192660 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98850349 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.98599883 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97204651 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92498883 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90054325 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88692299 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 0.86981529 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80085198 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 0.76772295 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.76721392 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76101366 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72902905 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72627014 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72387045 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70093085 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68999886 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68970520 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66084387 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65830949 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65439690 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62498773 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62336589 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60871412 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.60516241 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58498582 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57201474 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57109336 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.57065863 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57065257 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57044161 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56537801 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56323745 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.54006616 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53630171 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52877277 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52861755 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51643425 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49097429 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.47967896 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46317066 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46186367 |
| 89 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45579872 |
| 90 | Mismatch repair_Homo sapiens_hsa03430 | 0.44242533 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44047700 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43481225 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43007896 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.42806192 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42080565 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41718829 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41387998 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40689141 |
| 99 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40668557 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.40292665 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39015090 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.38295268 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38161695 |
| 104 | RNA degradation_Homo sapiens_hsa03018 | 0.37647538 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36180346 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35314181 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.34364624 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34044225 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33356755 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32709902 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32183529 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31771663 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31382068 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31201543 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.30950137 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.30890556 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.30492997 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.30144626 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26194704 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.23477388 |

